Hutch News

Hutch News

Stories tagged 'Business Development & Strategy'

Fred Hutch launches business partnership: LAB591

Collaboration aims to speed Hutch discoveries to patients

Sept. 26, 2018 | By Sabin Russell / Fred Hutch News Service

Fred Hutch, Arix Bioscience and Evotec AG have teamed up to launch LAB591, a partnership that aims to speed the development of new cancer and infectious disease therapeutics.

View story >


A focus on partnerships at Hutch/Merck summit

Research on the immune system aims to stop infectious diseases and cancer

May 11, 2018 | By Sabin Russell / Fred Hutch News Service

Article about a daylong Infectious Disease Summit hosted by Fred Hutch May 10 in Seattle.

View story >


Scientists-turned-entrepreneurs share lessons learned launching startups

From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found

March 26, 2018 | By Rachel Tompa / Fred Hutch News Service

Scientists who make the leap from academia to founding their own companies face a steep learning curve. There's a lot to learn and a lot to take in. But help is available.

View story >


Seattle mayor eager to realize the future of health care right here

Jenny Durkan addresses local life sciences representatives at Hutch roundtable

March 5, 2018 | By Josh Belzman for Fred Hutch News Service

Seattle Mayor Jenny Durkan and representatives of local life sciences organizations convened for a roundtable Feb. 27 at Fred Hutch.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 14, 2017

Fred Hutchinson Cancer Research Center has announced awards totaling $1 million to nine of its scientists through the Evergreen Fund, a unique grant program that supports homegrown research projects deemed attractive to potential commercial partners. This is the second year of Evergreen Fund awards. This is the second year of Evergreen Fund awards. The Hutch’s Business Development & Strategy office created the program in 2016 in an effort to encourage scientists to pursue creative ideas with commercial appeal. The goal is to speed research from the bench to the bedside while generating income from patent rights and partnerships with the business sector.

View story >


Preventing chemo-induced hearing loss

A new drug in development could avert permanent hearing loss associated with some chemotherapies, antibiotics

June 7, 2017 | By Rachel Tompa / Fred Hutch News Service

Fred Hutch and UW researchers are developing a drug that could prevent hearing loss associated with a certain chemotherapy and class of antibiotics.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.